Syros Pharmaceuticals Alternatives & Competitors
12 companies similar to Syros Pharmaceuticals — By redefining the power of small molecules to control gene expression, we aim to...
Companies similar to Syros Pharmaceuticals
Biosight Ltd.
Developing innovative pharmaceuticals for hematological malignancies and disorders
Lod, Israel
Geron Corporation
Changing lives by changing the course of blood cancer.
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Chordia Therapeutics Inc
We are passionate to deliver first in class cancer drugs to patients from Japan.
Fujisawa, Japan
Track all Syros Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Syntara
Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fi...
Australia
LAVA Therapeutics N.V.
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fi...
Utrecht, The Netherlands
Kura Oncology, Inc.
Our mission is to realize the promise of precision medicines to help patients with cancer...
San Diego, United States
CHARM Therapeutics
Protein-ligand intelligence to deliver next generation small molecule therapeutics
London, United Kingdom
Faron
A CLEVER Approach to Fight Cancer.
Turku, Finland
Cytovas
Empowering precision medicine through a pioneering cell-based informatics platform, delive...
Antengene
Treating Patients Beyond Borders.
Shanghai, China
Moleculin Biotech, Inc.
Groundbreaking Cancer Therapies
Houston, United States
About Syros Pharmaceuticals
Syros Pharmaceuticals, founded in 2012, is a trailblazer in the Biotechnology and Pharmaceutical industries, known for its mission: "By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients". Headquartered in the United States, Syros is focusing on develop...
Gene Expression Control, Hematologic Malignancies, Small Molecule Therapeutics, RARα Agonist, Myelodysplastic Syndrome, RARA Gene Overexpression, Oncology, Gene Regulatory Circuits, Drug Discovery, Bioinformatics, Assay Technologies, Genomic Data Integration, Biologic Insights
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Syros Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Syros Pharmaceuticals on 27 May 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
